SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000898430-03-001767
Filing Date
2003-03-03
Accepted
2003-03-03 16:20:59
Documents
8
Period of Report
2002-12-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K d10k.htm 10-K 1364638
3 EMPLOYMENT AGREEMENT DATED 3/12/02 dex1015.txt EX-10.15 8163
4 AMENDMENT TO LEASE AGREEMENT 12/23/96 dex1028.txt EX-10.28 2520
5 SECOND AMENDMENT TO LEASE dex1029.txt EX-10.29 2154
6 FORM OF LEASE FINANCING DOCUMENTS dex1034.txt EX-10.34 59986
7 LIST OF SUBSIDIARIES dex211.txt EX-21.1 1227
8 ACCOUNTANTS CONSENT dex231.txt EX-23.1 948
9 CERTIFICATION OF CEO AND CFO dex991.txt EX-99.1 1234
  Complete submission text file 0000898430-03-001767.txt   1443273
Mailing Address 371 BEL MARIN KEYS BLVD STE 210 NOVATO CA 94949
Business Address 371 BEL MARIN KEYS BLVD STE 210 NOVATO CA 94949 4158846700
BIOMARIN PHARMACEUTICAL INC (Filer) CIK: 0001048477 (see all company filings)

IRS No.: 680397820 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-26727 | Film No.: 03589608
SIC: 2834 Pharmaceutical Preparations